Search Within

Diane Lauren Reidy

  1. "Journal of Clinical Oncology"
Formats
  1. Meeting Abstract (81)
  2. Journal Article (7)
Groups
  1. Center for Pancreatic Cancer Research (88)
  2. Department of Medicine (88)
  3. Gastrointestinal Oncology Service (88)
  4. Solid Tumor Oncology Division (88)
  5. Survivorship Research (38)
  6. Department of Pathology and Laboratory Medicine (31)

More Groups

People
  1. Leonard Saltz (39)
  2. Andrea Cercek Hanjis (23)
  3. Nitya Raj (23)
  4. Neil Segal (22)
  5. Marinela Capanu (17)
  6. Zsofia Stadler (16)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (6)
  4. 2021 (5)
  5. 2020 (3)
  6. 2019 (10)

More Years

Publications
  1. Journal of Clinical Oncology (88)
Publishers
  1. American Society of Clinical Oncology (88)

Results (88)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing clinical research in a regional cancer center network: A survey-based approach
    Meeting Abstract

    Preeshagul, I. R.; Syldor, A.; Terzulli, S. L.; Gordon, R. A.; Evans, L. A.; Moran, S.; Eng, J.; Daly, R. M.; Rao, D.; Momtaz, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Safety and immunological effects of ablative radiotherapy followed by pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Crane, C. H.; Ziv, E.; Gopalan, A.; Chou, J. F.; Capanu, M.; Reidy, D. L.; Hajj, C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genetic profiling analysis design of well-differentiated aggressive grade 2 and 3 gastroenteropancreatic neuroendocrine tumors in the phase III randomized controlled COMPOSE trial
    Meeting Abstract

    Halfdanarson, T. R.; Capdevila, J.; Halperin, D. M.; Herrmann, K.; Kong, G.; Leyden, S.; Mailman, J.; Reidy-Lagunes, D.; Srirajaskanthan, R.; Erdòˆ, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)
    Meeting Abstract

    Cowzer, D.; Shah, R. H.; Punn, S.; Fiedler, L.; DeMore, A.; Chou, J. F.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; Raj, N. P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211)
    Meeting Abstract

    Kunz, P. L.; Graham, N.; Catalano, P. J.; Nimeiri, H.; Fisher, G. A.; Longacre, T. A.; Suarez, C. J.; Rubin, D.; Yao, J. C.; Kulke, M. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade
    Meeting Abstract

    Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy
    Meeting Abstract

    Daly, R. M.; Nicholas, K.; Flynn, J.; Panageas, K.; Silva, N.; Duck, E.; Zervoudakis, A.; Holland, J. C.; Salvaggio, R.; Begue, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early-onset well differentiated pancreatic neuroendocrine tumors: Clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C. A.; Reidy, D. L.; Wei, A. C. C.; Raj, N. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of neuroendocrine neoplasms treated with immune checkpoint inhibitors: A single-institution experience
    Meeting Abstract

    Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Pivotal phase III COMPOSE trial will compare (177)Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors
    Meeting Abstract

    Halfdanarson, T. R.; Reidy, D. L.; Vijayvergia, N.; Halperin, D. M.; Goldstein, G.; Kong, G.; Michael, M.; Leyden, S.; Grozinsky-Glasberg, S.; Sorbye, H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save